| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.0028 | 1 |